Evidence map›Paper›PMID 8817101›Full record

ArticleDiabetologia1996

Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production.

G Pugliese, F Pricci, N Locuratolo, G Romeo, G Romano, S Giannini, B Cresci, G Galli, C M Rotella, U Di Mario

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00685880 (Randomized, Double Blind Comparison Trial of Prolotherapy), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00685880 naterminatednot on this mapstarted 2008, after this paper: background citation

Randomized, Double Blind Comparison Trial of Prolotherapy (Dextrose) Compared to Corticosteroid Injection for the Treatment of Symptomatic Thumb Carpo-metacarpal Joint Arthritis

TypeinterventionalSponsorMayo ClinicRan2008 to 2010Enrolled2ConditionsThumb Carpometacarpal Joint OsteoarthritisArmsProlotherapy (10% dextrose solution), Betamethasone
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain.Clinical medicine insights. Arthritis and musculoskeletal disorders · 2016
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2005
    Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

G PuglieseDipartimento di Medicina Sperimentale (Cattedra di Patologia Generale I), La Sapienza University, Rome, Italy.
F Pricci
N Locuratolo
G Romeo
G Romano
S Giannini
B Cresci
G Galli
C M Rotella
U Di Mario
Sapienza University of Rome · ITUniversity of Florence · ITUniversity of Reggio Calabria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence suggests that several growth factors participate in diabetic glomerular disease by mediating increased extracellular matrix accumulation and altered cell growth and turnover leading to mesangial expansion. Transforming growth factor (TGF)-beta has been demonstrated to be upregulated both in vivo and in vitro, whereas studies on the activity of the renal insulin-like growth factor (IGF) system in experimental diabetes have provided conflicting results. We investigated the effects of prolonged exposure (4 weeks) of cultured human and rat mesangial cells to high (30 mmol/l) glucose vs iso-osmolar mannitol or normal (5.5 mmol/l) glucose levels on: 1) the autocrine/paracrine activity of the IGF system (as assessed by measuring IGF-I and II, IGF-I and II receptors, and IGF binding proteins); and, in parallel, on 2) TGF-beta 1 gene expression; 3) matrix production; and 4) cell proliferation. High glucose levels progressively increased the medium content of IGF-I and the mRNA levels for IGF-I and IGF-II, increased IGF-I and IGF-II binding and IGF-I receptor gene expression, and reduced IGF binding protein production. TGF-beta 1 transcripts and matrix accumulation and gene expression were increased in parallel, whereas cell proliferation was reduced. Iso-osmolar mannitol did not affect any of the above parameters. These experiments demonstrated that high glucose levels induce enhanced mesangial IGF activity, together with enhanced TGF-beta 1 gene expression, increased matrix production, and reduced cell proliferation. It is possible that IGFs participate in mediating diabetes-induced changes in matrix turnover leading to mesangial expansion, by acting in a paracrine/autocrine fashion within the glomerulus.

Indexed as

GlucoseAnimalsBlotting, NorthernCell DivisionCells, CulturedExtracellular Matrix ProteinsGene Expression RegulationGlomerular MesangiumHumansInsulin-Like Growth Factor Binding ProteinsInsulin-Like Growth Factor IInsulin-Like Growth Factor IIIodine RadioisotopesOsmolar ConcentrationRadioligand AssayRatsExtracellular Matrix ProteinsGlucoseInsulin-Like Growth Factor Binding ProteinsInsulin-Like Growth Factor IInsulin-Like Growth Factor IIIodine RadioisotopesReceptor, IGF Type 1RNA, MessengerTransforming Growth Factor beta

Identifiers

PMID8817101
OpenAlexW2088612802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.